He said his advice could "address a wide variety of matters," including distribution possible strategies for financing or recapitalization, possible stock buyback programs, and "potential strategies for confronting the speculative short position that currently exists in the Company's stock and its attendant negative publicity campaign." The statement is rather similar to that in Stiritz's November filing regarding Herbalife Ltd. (NYSE:HLF).